Association of intensive morphine treatment and increased stroke incidence in prostate cancer patients: A population-based nested case-control study

Japanese Journal of Clinical Oncology

Volumn 43, Issue 8, 2013, Pages 776-781

  Lee, Cynthia Wei Sheng ^a,b   Muo, Chih Hsin ^a,c   Liang, Ji An ^a,d   Sung, Fung Chang ^a,c   Kao, Chia Hung ^a,d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Morphine; Prostate cancer; Stroke

Indexed keywords

MORPHINE;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CANCER PATIENT; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EXPOSURE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORBIDITY; POPULATION BASED CASE CONTROL STUDY; PROSTATE CANCER; RETROSPECTIVE STUDY; STROKE PATIENT;

AGED; ANALGESICS, OPIOID; CASE-CONTROL STUDIES; DRUG ADMINISTRATION SCHEDULE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MORPHINE; MULTIVARIATE ANALYSIS; ODDS RATIO; PAIN; PAIN MANAGEMENT; PROSTATIC NEOPLASMS; REGISTRIES; RETROSPECTIVE STUDIES; STROKE; TAIWAN;

EID: 84881104407     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyt080     Document Type: Article

References (26)

1. Portenoy RK. Treatment of cancer pain. Lancet 2011;377:2236-47.
2. Goudas LC, Bloch R, Gialeli-Goudas M, Lau J, Carr DB. The epidemiology of cancer pain. Cancer Invest 2005;23:182-90.
3. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F. A validation study of the WHO method for cancer pain relief. Cancer 1987;59:850-6.
4. Gordon DB, Dahl JL, Miaskowski C, et al. American pain society recommendations for improving the quality of acute and cancer pain management: American Pain Society Quality of Care Task Force. Arch Intern Med 2005;165:1574-80.
5. Quigley C. Opioids in people with cancer-related pain. Clin Evid 2008;2008:2408.
6. Koyyalagunta D, Bruera E, Solanki DR, et al. A systematic review of randomized trials on the effectiveness of opioids for cancer pain. Pain Physician 2012;15:ES39-58.
7. Wiffen PJ, McQuay HJ. Oral morphine for cancer pain. Cochrane Database Syst Rev 2007;4:CD003868.
8. Flemming K. The use of morphine to treat cancer-related pain: a synthesis of quantitative and qualitative research. J Pain Symptom Manage 2010;39:139-54.
9. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012;62:220-41.
10. Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician 2008;11:S105-20.
11. Borne J, Riascos R, Cuellar H, Vargas D, Rojas R. Neuroimaging in drug and substance abuse part II: opioids and solvents. Top Magn Reson Imaging 2005;16:239-45.
12. Caplan LR, Hier DB, Banks G. Current concepts of cerebrovascular disease-stroke: stroke and drug abuse. Stroke 1982;13:869-72.
13. Sloan MA, Kittner SJ, Rigamonti D, Price TR. Occurrence of stroke associated with use/abuse of drugs. Neurology 1991;41:1358-64.
14. Jensen R, Olsen TS, Winther BB. Severe non-occlusive ischemic stroke in young heroin addicts. Acta Neurol Scand 1990;81:354-7.
15. Zhou Y, Fathali N, Lekic T, et al. Remote limb ischemic postconditioning protects against neonatal hypoxic-ischemic brain injury in rat pups by the opioid receptor/Akt pathway. Stroke 2011;42:439-44.
16. Esse K, Fossati-Bellani M, Traylor A, Martin-Schild S. Epidemic of illicit drug use, mechanisms of action/addiction and stroke as a health hazard. Brain Behav 2011;1:44-54.
17. Hagan IG, Burney K. Radiology of recreational drug abuse. Radiographics 2007;27:919-40.
18. Andersen SN, Skullerud K. Hypoxic/ischaemic brain damage, especially pallidal lesions, in heroin addicts. Forensic Sci Int 1999;102:51-9.
19. Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011;59:61-71.
20. Mottet N, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 2011;59:572-83.
21. Van Hemelrijck M, Garmo H, Holmberg L, et al. Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden. J Clin Oncol 2010;28:3448-56.
22. Alibhai SM, Duong-Hua M, Sutradhar R, et al. Impact of androgen deprivation therapy on cardiovascular disease and diabetes. J Clin Oncol 2009;27:3452-8.
23. Azoulay L, Yin H, Benayoun S, et al. Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer. Eur Urol 2011;60:1244-50.
24. Keating NL, O'Malley AJ, Freedland SJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer. J Natl Cancer Inst 2010;102:39-46.
25. Robinson D, Garmo H, Lindahl B, et al. Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe Sweden. Int J Cancer 2012;130:478-87.
26. Chung SD, Chen YK, Wu FJ, Lin HC. Hormone therapy for prostate cancer and the risk of stroke: a 5-year follow-up study. BJU Int 2012;109:1001-5.